Listing 1 - 10 of 213 | << page >> |
Sort by
|
Choose an application
Choose an application
Choose an application
Choose an application
This publication by the World Health Organization provides standard operating procedures for the determination of nicotine, glycerol, and propylene glycol in e-liquids, as well as the analysis of tobacco-specific nitrosamines in mainstream tobacco smoke. It is intended for use by laboratories participating in the Tobacco Laboratory Network (TobLabNet). The document outlines precise methodologies for testing under ISO and intense smoking conditions, ensuring accurate and consistent results. It aims to enhance consumer product safety and contribute to public health knowledge regarding the chemical composition of tobacco products. The intended audience includes scientists, researchers, and public health officials concerned with tobacco regulation and safety.
Choose an application
Choose an application
Nicotine and Other Tobacco Compounds in Neurodegenerative and Psychiatric Diseases: Epidemiological Data on Smoking and Preclinical and Clinical Data on Nicotine provides a comprehensive summary of the epidemiological data on smoking and several neurological disorders, including Alzheimer's disease, Parkinson's disease, Multiple Sclerosis, Tourette's syndrome, schizophrenia, anxiety, depression and ADHD, as well as preclinical and clinical data on the effects of nicotine. Despite the obvious and undisputed harmful nature of smoking, evidence suggests that some tobacco and tobacco smoke-derived constituents may offer neuroprotective effects, possibly in combinations, rather than individually. This unprecedented book describes the complex relationships between smoking and neurological disease and the bioactive compounds found in tobacco. It provides a comprehensive review of nicotine and other compounds found in tobacco plant, with scientific evidence of neuroprotective and anti-inflammatory effects that may act in conjunction with nicotine to exert neuroprotective effects observed in smokers. By presenting findings beyond harmful cigarette smoke effects, attention can be drawn to individual compounds of tobacco that may serve as inspiration for further therapy development.
Choose an application
This guideline covers support to stop smoking for everyone aged 12 and over, and help to reduce people's harm from smoking if they are not ready to stop in one go. It also covers ways to prevent children, young people and young adults aged 24 and under from taking up smoking. The guideline brings together and updates all NICE's previous guidelines on using tobacco, including smokeless tobacco. It covers nicotine replacement therapy and e-cigarettes to help people stop smoking or reduce their harm from smoking. It does not cover using tobacco products such as "heat not burn" tobacco.
Choose an application
Choose an application
Choose an application
Listing 1 - 10 of 213 | << page >> |
Sort by
|